Cargando…

Update on the NCEP ATP-III emerging cardiometabolic risk factors

The intent of this review is to update the science of emerging cardiometabolic risk factors that were listed in the National Cholesterol Education Program (NCEP) Adult Treatment Panel-III (ATP-III) report of 2001 (updated in 2004). At the time these guidelines were published, the evidence was felt t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eckel, Robert H, Cornier, Marc-Andre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283079/ https://www.ncbi.nlm.nih.gov/pubmed/25154373 http://dx.doi.org/10.1186/1741-7015-12-115

Ejemplares similares

The Burden of Statin Therapy based on ACC/AHA and NCEP ATP-III Guidelines: An Iranian Survey of Non-Communicable Diseases Risk Factors
por: Asgari, Samaneh, et al.
Publicado: (2018)

Quantifying the Effect of Applying the NCEP ATP III Criteria in a Managed Care Population Treated With Statin Therapy
por: Quilliam, Brian J., et al.
Publicado: (2004)

JIS Definition Identified More Malaysian Adults with Metabolic Syndrome Compared to the NCEP-ATP III and IDF Criteria
por: Ramli, Anis Safura, et al.
Publicado: (2013)

Prevalence of metabolic syndrome in Nepalese type 2 diabetic patients according to WHO, NCEP ATP III, IDF and Harmonized criteria
por: Pokharel, Daya Ram, et al.
Publicado: (2014)

Relationship of metabolic syndrome defined by IDF or revised NCEP ATP III with glycemic control among Malaysians with Type 2 Diabetes
por: Saif-Ali, Riyadh, et al.
Publicado: (2020)

The modified NCEP ATP III criteria maybe better than the IDF criteria in diagnosing Metabolic Syndrome among Malays in Kuala Lumpur
por: Moy, Foong Ming, et al.
Publicado: (2010)

A Comparison of the Prevalence of the Metabolic Syndrome among Sri Lankan Patients with Type 2 Diabetes Mellitus Using WHO, NCEP-ATP III, and IDF Definitions
por: Herath, H. M. M., et al.
Publicado: (2018)

A Comparison between Revised NCEP ATP III and IDF Definitions in Diagnosing Metabolic Syndrome in an Urban Sri Lankan Population: The Ragama Health Study
por: Chackrewarthy, S., et al.
Publicado: (2013)

2013 ACC/AHA Cholesterol Guideline Versus 2004 NCEP ATP III Guideline in the Prediction of Coronary Artery Calcification Progression in a Korean Population
por: Cho, Yun Kyung, et al.
Publicado: (2016)

A Comparative Study of Metabolic Syndrome Using NCEP—ATP III and IDF Criteria in Children and Its Relationship with Biochemical Indicators in Huatusco, Veracruz, Mexico
por: Rivadeneyra-Domínguez, Eduardo, et al.
Publicado: (2023)

Effects of low carbohydrate diet compared to low fat diet on reversing the metabolic syndrome, using NCEP ATP III criteria: a randomized clinical trial
por: Ismael, Sherzad Ali
Publicado: (2021)

Assessing compliance of cardiologists with the national cholesterol education program (NCEP) III guidelines in an ambulatory care setting
por: Aliyu, Zakari Y, et al.
Publicado: (2004)

Lack of chart reminder effectiveness on family medicine resident JNC-VI and NCEP III guideline knowledge and attitudes
por: Echlin, Paul S, et al.
Publicado: (2004)

Assessing the prevalence of the Metabolic Syndrome according to NCEP ATP III in Germany: feasibility and quality aspects of a two step approach in 1550 randomly selected primary health care practices
por: Moebus, Susanne, et al.
Publicado: (2006)

A Compiled Update on Nutrition, Phytochemicals, Processing Effects, Analytical Testing and Health Effects of Chenopodium album: A Non-Conventional Edible Plant (NCEP)
por: Singh, Sukhwinder, et al.
Publicado: (2023)

The Prevalence of the Metabolic Syndrome in Korean Adults: Comparison of WHO and NCEP Criteria
por: Choi, Sung Hee, et al.
Publicado: (2005)

Advancing early warning capabilities with CHIRPS-compatible NCEP GEFS precipitation forecasts
por: Harrison, Laura, et al.
Publicado: (2022)

Frequency of metabolic syndrome in obesity: a comparison of current criteria of IDF and NCEP-ATPIII
por: Nascimento, Luana Costa, et al.
Publicado: (2015)

Skeletal muscle munc18c and syntaxin 4 in human obesity
por: Bergman, Bryan C, et al.
Publicado: (2008)

Metabolic syndrome and population attributable risk among HIV/AIDS patients: comparison between NCEP-ATPIII, IDF and AHA/NHLBI definitions
por: Alencastro, Paulo R, et al.
Publicado: (2012)

The role of NAFLD in cardiometabolic disease: an update
por: Faasse, Sarah, et al.
Publicado: (2018)

Agreement Between the JCDCG, Revised NCEP-ATPIII, and IDF Definitions of Metabolic Syndrome in a Northwestern Chinese Population
por: Sun, Fei, et al.
Publicado: (2018)

Greater hunger and less restraint predict weight loss success with phentermine treatment
por: Thomas, Elizabeth A., et al.
Publicado: (2015)

Emergence of cardiometabolic risk in Bangladesh
por: Gupta, Rajeev
Publicado: (2016)

Comprehensive Care Models for Cardiometabolic Disease
por: Reiter-Brennan, Cara, et al.
Publicado: (2021)

Critical Role of the Human ATP-Binding Cassette G1 Transporter in Cardiometabolic Diseases
por: Hardy, Lise M., et al.
Publicado: (2017)

Tooth brushing and cardiometabolic risk factors in adolescents: Is there an association? The CASPIAN-III study
por: Kelishadi, Roya, et al.
Publicado: (2013)

Association of ghrelin with cardiometabolic risk factors in Iranian adolescents: the CASPIAN-III study
por: Heshmat, Ramin, et al.
Publicado: (2016)

Sugar-Sweetened Beverages and Cardiometabolic Health: An Update of the Evidence
por: Malik, Vasanti S., et al.
Publicado: (2019)

Gender Differences and Cardiometabolic Risk: The Importance of the Risk Factors
por: Meloni, Antonella, et al.
Publicado: (2023)

Complement C3: an emerging risk factor in cardiometabolic disease
por: Hertle, E., et al.
Publicado: (2012)

Influence of Cardiometabolic Risk Factors on Platelet Function
por: Barale, Cristina, et al.
Publicado: (2020)

Precipitable Water Vapour Retrieval from GPS Precise Point Positioning and NCEP CFSv2 Dataset during Typhoon Events
por: Tang, Xu, et al.
Publicado: (2018)

Journey in guidelines for lipid management: From adult treatment panel (ATP)-I to ATP-III and what to expect in ATP-IV
por: Talwalkar, P. G., et al.
Publicado: (2013)

Obesity and Cardiometabolic Risk Factors: From Childhood to Adulthood
por: Drozdz, Dorota, et al.
Publicado: (2021)

Does Nut Consumption Reduce Mortality and/or Risk of Cardiometabolic Disease? An Updated Review Based on Meta-Analyses
por: Kim, Yoona, et al.
Publicado: (2019)

An update on overweight and obesity in rural Northeast China: from lifestyle risk factors to cardiometabolic comorbidities
por: Guo, Xiaofan, et al.
Publicado: (2014)

Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders
por: Mingorance, Carmen, et al.
Publicado: (2011)

Autophagy and cardiometabolic risk factors
por: Juárez-Rojas, Juan G., et al.
Publicado: (2014)

Hypertension and Cardiometabolic Risk Factors
por: Neves, Mario Fritsch, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_jba1d567c9p2hotjper69tnjfi